Background-Little is known about the optimum way to deliver exercise to older, functionally impaired patients with heart failure. We tested whether an exercise program tailored to the needs of these patients could improve exercise capacity and quality of life or reduce costs to the National Health Service. Methods and Results-The study design was a parallel-group, single-blind, randomized controlled trial. Patients aged Ն70 years with symptomatic heart failure and left ventricular systolic dysfunction were randomized to either 24 weeks of exercise training or usual care. Six-minute walk distance was the primary outcome; markers of physical function, quality of life, health status, and daily activity were measured at baseline and 8 and 24 weeks. Carer strain and healthcare costs were also recorded. A total of 107 participants were randomized (mean age, 80 years; men, 72 [67%]). Six-minute walk distance did not improve compared to that of the control group at 8 weeks (Ϫ16.9 m; 95% CI, Ϫ41.8 to 7.9 m; Pϭ0.18) or at 24 weeks (Ϫ5.3 m; 95% CI, Ϫ32.6 to 22.0 m; Pϭ0.70). For secondary outcomes, only the sit-to-stand test improved significantly at 24 weeks (Ϫ6.4 s; 95% CI, Ϫ12.2 to 0.6 s; Pϭ0.03); there was no difference in change for the Minnesota Living With Heart Failure score (0.1 points; 95% CI, Ϫ0.9 to 1.1 points; Pϭ0.83) at 24 weeks. Carer strain did not decrease at 24 weeks (difference, Ϫ0.5 points; 95% CI, Ϫ8.3 to 7.3 points; Pϭ0.80), and there was no difference in overall healthcare costs.
H eart failure is a common and important cause of disability and poor quality of life in older people, 1, 2 and this burden is incompletely relieved by pharmacological therapies. Exercise training has been shown to be effective at improving exercise capacity and quality of life in younger patients as well as in reducing death and hospitalization, 3 and recent UK National Institute for Health and Clinical Excellence guidance recommends that group-based exercise training be offered to patients with stable heart failure. However, the most recent Cochrane review 4 once again highlighted the dearth of evidence for exercise training applicable to older patients with heart failure.
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Comorbid disease and functional impairment are the norm in older patients with heart failure 5 ; thus, exercise programs suitable for older people need to be designed to circumvent these limitations. Programs need to be sustainable because the benefits of exercise are lost rapidly on cessation. 6 Programs designed for older people require testing; efficacy cannot be assumed because previous programs have not delivered the expected benefits. 7, 8 In a previous trial, we found that patients with low baseline 6-minute walk (6MW) distances improved more than those with higher baseline exercise capacity, suggesting that the exercise program was insufficiently intensive to benefit fitter patients. We designed a more intensive exercise program aimed specifically at older, functionally impaired patients with heart failure. 9 Initial testing showed high levels of acceptability and attendance, with potentially promising effects on exercise capacity and activities of daily living. The aim of the present study was to test the efficacy of this program in a blinded, randomized controlled trial.
Methods

Study Design and Population
The study was a parallel-group, single-blind, randomized controlled trial. Participants were recruited from primary care, Medicine for the Elderly Clinics and Day Hospitals, and heart failure and cardiology outpatient clinics within Tayside, Scotland. Inclusion criteria were aged Ն70 years with a confirmed diagnosis of heart failure due to left ventricular systolic dysfunction (New York Heart Association functional classes II and III) and a history of symptoms and signs of congestive heart failure. Patients were excluded if they were wheelchair bound, were unwilling or unable to give informed consent, had aortic stenosis with peak gradient Ͼ30 mm Hg, experienced sustained ventricular tachycardia or ventricular fibrillation outside the context of an acute myocardial infarction, and currently (within the past month) had unstable angina or atrial fibrillation with a ventricular rate of Ͼ100 per minute. The study conformed to the principles of the Declaration of Helsinki and was approved by the Tayside Committee on Medical Research Ethics (reference 07/S1401/1).
Randomization and Treatment Allocation
Written informed consent was obtained, and participants were randomly allocated to either exercise or usual care only (control group). Using an off-site telephone randomization service, randomization was performed without stratification and with block sizes between 8 and 16, depending on the size of each planned exercise class. After completing baseline assessments, the project coordinator passed the participants' details to the research physiotherapist who obtained group allocation, ensuring that the project coordinator remained blind to group assignments.
Exercise Intervention
The first phase consisted of twice-weekly exercise classes held in the Medicine for the Elderly Day Hospital for 8 weeks and delivered by an experienced physiotherapist. This was followed by a 16-week phase of home exercise. During the home phase, participants were telephoned every 2 weeks for 8 weeks by the physiotherapist, then monthly for the final 8 weeks.
The exercise program has been described previously, 9 and the full materials are available from the authors. It comprised an initial individualized assessment in each participant's own home followed by an individually tailored intervention. A mixture of intermittent functional aerobic exercise and strength training was used, with resistance provided by the use of elasticized bands (PhysioMed). Exercise duration was gradually increased to a maximum of 60 minutes. The intensity of the exercise was also increased incrementally by raising the number of repetitions of each exercise, and the resistance level of the elasticized bands. Sessions opened with a warm-up period and closed with a seated cool-down period. Maximum oxygen consumption calibration of exercise intensity was deliberately avoided given the difficulty of routinely performing such testing in this patient group.
Guided discussion sessions based on cognitive and behavioral techniques were incorporated into this phase, focusing on benefits of exercise, working out the starting point for exercises and activities, goals and how to work toward them, relaxation techniques, how thoughts and feelings affect symptoms, and dealing with setbacks. A written, structured educational package accompanied the exercise groups, reinforcing the topics covered in the group discussion.
The supervised exercise period was followed by a 16-week period of home-based exercise, continuing the resistance exercises and shuttle walking as performed in the group phase. Participants used daily self-monitoring logs to record goals, strategies for dealing with setbacks, and estimates of time engaged in exercise. The physiotherapist telephoned to motivate participants to achieve their goals (eg, walking to the shops, walking around the block) and to troubleshoot any problems that arose. Participants were encouraged to perform self-paced shuttle walking within their homes as space allowed and to set goals for walking outside the home. Participants were asked to continue with the resistance exercises, functional exercises, and walking at least twice a week at home, continuing to build the number of repetitions undertaken.
Participants in the usual care group were given a booklet with general advice on diet, exercise, and lifestyle. Participants in the usual care group were not discouraged from exercising if they were already in the habit of doing so.
Carer Involvement
Participants were asked to nominate the person they regarded as their informal carer (spouse, other relative, or friend). Written informed consent was obtained from carers willing to take part. Carers were encouraged to attend exercise sessions if the participant was randomized to the exercise group.
Outcome Measures
Outcome measures were assessed by the project coordinator at baseline and 8 and 24 weeks in a hospital outpatient setting. The primary outcome measure was the change in 6MW distance at 24 weeks. The 6MW test is a validated, safe, reliable, and repeatable measure of functional status and submaximal exercise capacity in older persons. 10 Although it lacks the prognostic precision of the maximum oxygen consumption test, it can be easily performed by a much wider range of older persons, including those using walking aids, and reflects everyday activity, making the results more patient centered than maximal tests of exercise capacity. Tests were performed using a standardized approach over a 25-m course. Participants used their usual walking aids and received standardized encouragement at regular intervals.
Quadriceps strength was measured using a hand-held dynamometer (Lafayette 01153). The average of 2 maximal isometric leg extensions were taken with the participant seated, the knee joint at 90°, and the dynamometer held anteriorly between the malleoli. The sit-to-stand test was performed to assess functional musculoskeletal capacity relevant to everyday activity. 11 Physical activity levels were measured objectively using the RT3 Triaxial accelerometer (Stay Healthy Inc) during waking hours for 7 days. 7, 12 Disease-specific quality of life was measured with the Minnesota Living With Heart Failure questionnaire. 13, 14 The Functional Limitations Profile 15 a general health status tool, and the Hospital Anxiety and Depression scale 16 were also administered. The Zarit Burden Interview 17 (an index of carer strain) was administered to participating carers. Cognitive function was measured using the 30-point Mini-Mental State Examination, 18 and generic health-related quality of life was measured using the EuroQoL-5D tool. 19 Dropouts, reasons for dropouts, and adherence with supervised exercise were recorded at each study visit. All adverse events, including hospital admission, morbidity and mortality, and medication changes were recorded.
The average total cost of the intervention and other healthcare use was estimated for each patient participating in the trial. The cost of the intervention included physiotherapist time, travel of the physiotherapist and the participant, and equipment. Healthcare resource utilization data (secondary, primary, and pharmaceutical care) were collected through a participant-administered questionnaire at baseline, week 8, and week 24 and were analyzed using standard UK costing sources, including the Scottish Information Services Division unit costs for secondary care, the Personal Social Services Research Unit costs for primary care, and the British National Formulary for unit costs of pharmaceutical care. 20 -22 
Sample Size Calculation
The study was powered to detect a 30-m change in walking distance, equivalent to the minimum clinically important difference for the 6MW in older patients with heart failure. 10 A sample size of 90 participants (45 per group) would have 80% power to detect an increase in 6MW distance (assuming an SD change of 50 m) of 30 m from a baseline of 260 m 7 at ␣ϭ0.05. We aimed to recruit 112 participants in anticipation of a 20% dropout rate at 20 weeks to yield a final evaluable sample of 90. Our pilot study showed a 19-m improvement in 6MW distance over a 12-week follow-up period; therefore, we anticipated further improvement over 24 weeks of follow-up.
Statistical Analysis
Statistical analyses were performed before breaking the treatment code. Analyses were by intention to treat, using SPSS version 17 statistical software. Change between baseline and follow-up points was calculated for each outcome; changes in scores were compared using ANOVA, with adjustment for the baseline score and other factors significantly different between the groups at baseline. Sensitivity analyses were undertaken for the primary outcome, first by allocating a value of 0 to missing data and second, by using the last value carried forward. Multiple imputation (combining 10 imputation sets) was undertaken for the primary outcome to adjust for missing data.
For the cost analysis, the mean total over the whole trial follow-up is relevant rather than changes between the different time points. Mean total costs for each group were compared using ordinary least squares regression with adjustment for baseline cost and other group differences. Because cost data tend to be skewed, the nonparametric technique of bootstrapping was used to estimate CIs. Multiple imputation was undertaken for the main analysis. The impact of using complete cases only and of removing outlying cost data was explored in a sensitivity analysis.
Results
A total of 107 participants were randomized. The Figure shows the CONSORT (Consolidated Standards of Reporting Trials) flow diagram for progress through the trial. Dropouts were equally distributed between the intervention and control groups. Eight-seven of the 107 (81%) of participants attended the 24-week outcomes visit, close to the predicted dropout rate of 20%. Baseline details of all randomized participants are given in Table 1 .
Delivery of Intervention
The exercise program was delivered to 53 participants in a total of 10 groups. A total of 850 person-sessions were offered, of which 704 (83%) were attended. Forty-one of 53 (77%) participants attended Ն80% of the sessions offered to them (the predefined threshold for full attendance). The number of upper-limb elasticized resistance band repetitions performed increased from 14 at baseline to 35 at 8 weeks, and lower-limb repetitions increased from 8 to 27 (both PϽ0.001). Mean sit-to-stand repetitions increased from 10 to 32; alternate knee raises, from 12 to 37; wall press-ups, from 12 to 44; and step-ups, from 14 to 56 (all PϽ0.001). The median type of elasticized band used increased from type 1 (light resistance) at baseline to type 3 (heavy resistance) at 8 weeks (PϽ0.001 by Wilcoxon test). Table 2 shows the adjusted main outcomes of the trial. No significant between-group differences were seen for any analysis of the primary outcome. Multiple imputation analysis showed that the 6MW distance changed by Ϫ10.8 m (95% CI, Ϫ35.7 to 14.1 m; Pϭ0.40) in the intervention group relative to the control group between baseline and 8 weeks and changed by 2.0 m (95% CI, Ϫ23.1 to 27.1 m; Pϭ0.88) between baseline and 24 weeks. Sensitivity analyses showed that for the worst-case analysis (missing 6MW distance data set to 0), the 6MW distance changed by Ϫ15.7 m (95% CI, Ϫ57.8 to 26.4 m) in the intervention group relative to the control group between baseline and 8 weeks. The difference between baseline and 24 weeks was 4.7 m (95% CI, Ϫ37.1 to 46.5 m). For the best-case scenario (last value carried forward for missing 6MW data), the intervention group changed by Ϫ10.6 m (95% CI, Ϫ30.2 to 8.9 m) relative to the control group between baseline and 8 weeks; between baseline and 24 weeks, the change was Ϫ1.8 m (95% CI, Ϫ23.1 to 19.5).
Main Outcomes Data
Sit-to-stand performance improved significantly in the exercise group at 24 weeks compared with the control group. No significant between-group differences were seen when analyzing the physical and mental subscales of the Minnesota Living With Heart Failure questionnaire.
Safety and Adverse Events
Two participants reported joint pain as a direct result of the exercises (1 knee, 1 shoulder). One participant reported an exacerbation of sciatic pain. One participant with known angina experienced a self-limiting episode of angina, and 1 participant fell during a class. No participant was hospitalized as a result of any of these events.
A total of 41 adverse events were recorded in the intervention group over the 24-week study period compared to 39 events in the control group. Seven participants in the intervention group reported increased breathlessness (3 in the control group), and 6 participants in the intervention group reported worsening of bilateral ankle edema (2 in the control group). Seven musculoskeletal adverse events occurred in the intervention group compared to 10 in the control group. There were 14 hospitalizations and 2 deaths in the intervention group compared to 11 hospitalizations and 1 death in the control group. None of the between-group differences reached statistical significance.
Carer Outcomes
Carers were nominated and able to give data for 71 of 107 (66%) participants. Only 10 of the nominated carers accepted the invitation to attend and participate in the supervised exercise classes, attending a range of 1 to 16 sessions. Table  3 provides baseline details and change scores for carers.
Cost Analysis
The cost of the exercise intervention was estimated at £474.75 per participant (Table 4 ). Complete cost data existed for 66 of the 107 participants, with missing data evenly distributed between the groups (20 missing in the intervention group, 21 missing in the control group). The results ( Table 5) show that the mean costs in the intervention group were lower than in the control group but that the difference was not statistically significant. Sensitivity analyses showed that the results were not sensitive to whether data imputation was used. When removing 3 participants who spent Ͼ30 days in the hospital for reasons other than heart failure or the exercise intervention, the mean costs in the intervention group were nonsignificantly higher than in the control group.
Discussion
We found no improvement in exercise capacity, mood, quality of life, physical function, carer strain, or cost savings in terms of use of National Health Service resources in this trial of a tailored exercise intervention for older, functionally impaired patients with heart failure. This finding was despite careful piloting of the intervention, high attendance rates during the hospital phase of the intervention, and use of a range of outcome measures designed to capture different aspects of physical function, symptoms, quality of life, and interaction with carers. Participants in the present trial were similar in both exercise capacity and symptom class to those who we had studied previously. 7, 23 The minimum clinically important difference for the 6MW test is 30 m in older patients with heart failure. 10 This lies well outside the 95% CI for the between-group change in the 6MW test seen in the current study at both 8 and 24 weeks, making it highly unlikely that we have missed a clinically significant effect.
Previous studies have shown that in younger patients with heart failure, exercise training can improve exercise capacity and health-related quality of life, 4 reduce hospital admissions, and reduce death rates. 3 However, the recent large HF-ACTION (Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure) study 24, 25 revealed a somewhat weaker effect than anticipated, with no difference in all-cause mortality and a borderline reduction in all-cause mortality and hospitalization. Patients in HF-ACTION were young (median age, 59 years) and predominantly men (72%). Health-related quality of life, as measured by the Kansas City Cardiomyopathy Questionnaire score, improved by only 1.9 points in the exercise group, which was considerably less than the minimum clinically important difference of 5 points for this measure. The median change in 6MW distance between groups at 3 months was only 15 m in HF-ACTION, with no difference noted at 12 months. A similar lack of effect on 6MW and maximum oxygen consumption was seen in another recent trial of exercise training in older patients with heart failure, 8 using a more intensive, more frequent intervention (3 times weekly training for 16 weeks using cycle ergometry at 70% of heart rate reserve).
Translation of promising small-scale exercise studies into real-life clinical settings is proving difficult, especially in older people. Possible reasons are (1) the intervention is insufficiently intensive to produce change, (2) adherence (especially during the home exercise phase) is inadequate, or (3) exercise training is not efficacious in changing the underlying pathophysiology in older patients with heart failure. Both resistance and aerobic training have shown effects in older patients with heart failure in some trials, 26, 27 and we included elements of both in our program. It is still possible that the intensity or frequency of exercise was insufficient in our intervention, 28 but it may not be feasible to increase intensity or frequency further in functionally impaired patients with comorbid disease. Adherence with home exercise is known to fall with time, 29 but this does not explain the lack of effect of the current intervention at 8 weeks because attendance was high during this hospital-based phase. Daily activity levels did not increase appreciably in either group, suggesting that a degree of activity homeostasis may have taken place, with increases in activity because of exercise being counterbalanced by a decrease in other activities in the exercise group. This may have blunted any benefit of exercise training on physical fitness and quality of life. It is perhaps unsurprising that carer strain did not change, given the lack of effect of the intervention on patients; it is, however, reassuring that carer strain did not increase as a result of introducing the intervention, as has been seen previously in exercise trials in older patients with heart failure. 30 It is possible that exercise capacity in very old patients with heart failure is not limited by the skeletal myopathy of heart failure or by symptoms of breathlessness. If exercise capacity is limited by comorbid disease (eg, arthritis, Parkinson disease) or by the type II muscle fiber myopathy seen in the sarcopenia of aging, it is possible that exercise interventions may be less efficacious in this patient group compared to relatively younger older patients. 26, 31 
Limitations
The current study was performed at a single center, with consequent limits on generalizability. Although the intervention contained elements of education, it did not provide a comprehensive approach to disease management in the way that some cardiac rehabilitation interventions have done; it is possible that such an approach, rather than exercise alone, is necessary to produce change in older patients with heart failure. 26
Generalizability
In contrast with many previous trials of exercise training for heart failure, the current study population was typical of the general population of patients with heart failure. 1 The mean age was similar to that seen in population-based studies, and participants had a heavy burden of comorbid disease. 5 Rates of renin-angiotensin system blockers and ␤-blockers were consistent with rates previously reported in older, functionally impaired patients in whom multiple contraindications often exist. 28 The exercise intervention was delivered in a way that mirrors what is achievable in clinical practice, with a limited initial hospital phase followed by home follow-up. Finally, a range of outcome measures of direct relevance to both patients and their carers was measured. These aspects of study design, delivery, and measurement work to enhance the generalizability and applicability of the findings.
Conclusions
The results do not support the usefulness of this exercise program for older patients with heart failure. More work is required to find a method of delivering exercise training to typical older, functionally impaired patients with heart failure either through more-intensive exercise, by better targeting patients who are limited by breathlessness, or by combining exercise with education and behavioral interventions in a comprehensive package. 
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